Himadri Speciality Chemical (500184) Q4 06/07 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 06/07 earnings summary
19 Oct, 2026Executive summary
FY07 delivered strong growth: total income rose 88.43% to Rs 32,921.12 lac, EBITDA 153.32% to Rs 10,363.07 lac and PAT 156.11% to Rs 6,156.99 lac.
Domestic coal tar pitch market share was ~70%; strategy shifted toward global expansion, value-added products and advanced carbon materials.
Financial highlights
Gross turnover increased 88.76% to Rs 39,069.98 lac; net sales reached Rs 32,598.32 lac, up 88.93% YoY.
Operating profit rose 153.32% to Rs 10,363.07 lac; PBT was Rs 8,154 lac and PAT Rs 6,156.99 lac, up 164.26% and 156.11%, respectively.
Cash profit increased 125.31% to Rs 7,935.65 lac; EPS rose 137.69% to Rs 22.39.
Outlook and guidance
Targeting 1 million MTPA combined coal tar distillation capacity by 2010: 400,000 MTPA in India and 600,000 MTPA in China.
Indian capacity plan expands to 400,000 MTPA by 2010; commercial advanced carbon production, refined naphthalene and further value-added products are planned.
Management expected growth in sales and profitability to continue; value-added products were targeted to become the major revenue source by 2010.
Latest events from Himadri Speciality Chemical
- Higher sales lifted profit as a major capacity expansion moved forward.500184
Q4 02/03 - Profit rose as expansion targeted more than double capacity; coal-tar scarcity remained a risk.500184
Q4 03/04 - PAT rose 132% as new capacity came online amid feedstock shortages.500184
Q4 04/05 - Record profit growth and capacity expansion positioned the business to pursue rising pitch demand.500184
Q4 05/06 - EBITDA and exports advanced as one-off inventory and FX losses cut net profit.500184
Q4 08/09 - Profit and margins rose as expansion shifted the portfolio beyond coal-tar pitch.500184
Q4 07/08 - Lower FY20 earnings met cash discipline and a strategic push into speciality carbon products.500184
Q4 19/20 - Strong earnings growth and new capacity set the stage for a major expansion cycle.500184
Q4 09/10 - Q2 growth and advanced-materials investment advanced as FY28 PAT guidance was reaffirmed.500184
Q2 26/27